Fetal ductus arteriosus constriction and heart failure following maternal cyclooxygenase-2 inhibitor ingestion: A case report / 대한산부인과학회지
Korean Journal of Obstetrics and Gynecology
;
: 771-776, 2008.
Article
in English
| WPRIM
| ID: wpr-54305
ABSTRACT
We report a case of premature constriction of the fetal ductus arteriosus following maternal ingestion of a cyclooxygenase-2 (COX-2) inhibitor at 37 weeks' gestation. Fetal sonography at 38+2 weeks' gestation revealed tricuspid regurgitation, absent transpulmonary valve flow, right heart enlargement, and pericardial effusion. An immediate delivery resulted in a good postnatal outcome with dramatic improvement in the clinical and echocardiographic findings. Maternal exposure to Non-steroidal anti-inflammatory drugs (NSAIDs), especially late in gestation, can cause premature constriction of the ductus arteriosus, heart failure, and fetal death. Therefore, the use of NSAIDs late in gestation should be considered in limited cases with close fetal heart monitoring.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Pericardial Effusion
/
Sulfonamides
/
Tricuspid Valve Insufficiency
/
Anti-Inflammatory Agents, Non-Steroidal
/
Cardiomegaly
/
Maternal Exposure
/
Constriction
/
Ductus Arteriosus
/
Eating
/
Cyclooxygenase 2
Limits:
Pregnancy
Language:
English
Journal:
Korean Journal of Obstetrics and Gynecology
Year:
2008
Type:
Article
Similar
MEDLINE
...
LILACS
LIS